secwatch.observer — SEC 8-K summary
======================================

Issuer:     Adicet Bio, Inc. (ACET)
CIK:        0001720580
Form:       8-K
Filed at:   2024-06-07T23:59:59+00:00
Accession:  0000950170-24-070568
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 5.07, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Adicet Bio stockholders approve doubling authorized shares to 300M and 5M share plan increase
--------------------------------------------------------------------------------

- Authorized common shares increased from 150M to 300M via charter amendment; filed June 6.
- 2018 Stock Plan increased by 5M shares to 16.6M total; approved with 28.9M votes for.
- Contingent option grants become effective: CEO Chen Schor receives 1.77M options; CFO Nick Harvey 375k; total 3.3M across management.
- Charter amendment adopted to limit officer liability as permitted by Delaware law.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1720580/000095017024070568/0000950170-24-070568-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1720580/000095017024070568/acet-20240605.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-070568

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer